Anticancer Therapy Targeting Telomeres and Telomerase: Current Status

ISSN： 1173-8804

Source： BioDrugs, Vol.21, Iss.6, 2007-01, pp. : 375-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Status and Challenges Associated with Targeting mTOR for Cancer Therapy

By Dowling Ryan J.O.

BioDrugs, Vol. 23, Iss. 2, 2009-06 ,pp. : 77-91

Adis International

Access to resources Recommend Favorite

Targeting Mitosis for Anti-Cancer Therapy

By Sudakin Valery

BioDrugs, Vol. 21, Iss. 4, 2007-01 ,pp. : 225-233

Adis International

Access to resources Recommend Favorite

Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor: Current Status and Future Challenges in Cancer Therapy

By Hsu Jerry Y. Wakelee Heather A.

BioDrugs, Vol. 23, Iss. 5, 2009-10 ,pp. : 289-304

Adis International

Access to resources Recommend Favorite

Current Advances in the Development of Anticancer Drugs Targeting Tyrosine Kinases of the Src Family

Current Drug Therapy, Vol. 3, Iss. 3, 2008-09 ,pp. : 158-176

Bentham Science Publishers

Access to resources Recommend Favorite

Current Status of Gene Therapy for Rheumatoid Arthritis

By Reinecke J.

BioDrugs, Vol. 11, Iss. 2, 1999-02 ,pp. : 103-114

Adis International

Access to resources Recommend Favorite